Total Payments
$61,691
2024 Payments
$21,751
Companies
34
Transactions
443
Medicare Patients
3,404
Medicare Billing
$437,732
Payment Breakdown by Category
Other$43,486 (70.5%)
Food & Beverage$7,845 (12.7%)
Consulting$7,630 (12.4%)
Travel$2,449 (4.0%)
Education$281.15 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,956 | 29 | 56.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,030 | 9 | 13.0% |
| Food and Beverage | $7,845 | 383 | 12.7% |
| Consulting Fee | $7,630 | 4 | 12.4% |
| Travel and Lodging | $2,449 | 10 | 4.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.8% |
| Education | $281.15 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,920 | 122 | $0 (2024) |
| Allergan, Inc. | $17,490 | 37 | $0 (2021) |
| Eisai Inc. | $17,251 | 52 | $0 (2024) |
| LivaNova USA, Inc. | $1,832 | 12 | $0 (2024) |
| Lilly USA, LLC | $1,115 | 36 | $0 (2024) |
| UCB, Inc. | $524.79 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $450.18 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $366.84 | 7 | $0 (2024) |
| Biogen, Inc. | $280.73 | 9 | $0 (2024) |
| SK Life Science, Inc. | $192.73 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,751 | 178 | Eisai Inc. ($17,075) |
| 2023 | $6,266 | 101 | ABBVIE INC. ($4,695) |
| 2022 | $5,331 | 34 | ABBVIE INC. ($5,009) |
| 2021 | $10,751 | 52 | AbbVie Inc. ($7,831) |
| 2020 | $15,185 | 39 | Allergan, Inc. ($14,754) |
| 2019 | $602.48 | 19 | Lilly USA, LLC ($176.00) |
| 2018 | $577.18 | 8 | LivaNova USA, Inc. ($511.42) |
| 2017 | $1,227 | 12 | LivaNova USA, Inc. ($1,087) |
All Payment Transactions
443 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $730.00 | General |
| Category: Neurology | ||||||
| 12/18/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: EPILEPSY | ||||||
| 12/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: Neurology | ||||||
| 12/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $365.00 | General |
| Category: Neurology | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $69.78 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Neurology | ||||||
| 11/13/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 538 | 656 | $180,605 | $65,674 |
| 2022 | 14 | 708 | 6,379 | $308,710 | $90,655 |
| 2021 | 18 | 1,066 | 9,546 | $481,387 | $138,451 |
| 2020 | 19 | 1,092 | 12,205 | $516,807 | $142,952 |
Total Patients
3,404
Total Services
28,786
Medicare Billing
$437,732
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 221 | $53,703 | $19,226 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 82 | 82 | $34,522 | $12,451 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 95 | $32,585 | $12,268 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $23,214 | $7,885 | 34.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 45 | 85 | $15,895 | $6,109 | 38.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 33 | 34 | $8,806 | $3,388 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 54 | $9,288 | $3,352 | 36.1% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 12 | 12 | $2,592 | $995.04 | 38.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 13 | 5,604 | $79,742 | $27,196 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 179 | $33,477 | $14,722 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $25,681 | $9,404 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 65 | 68 | $24,119 | $8,678 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $21,210 | $7,847 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 99 | $13,266 | $5,992 | 45.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 76 | $22,272 | $5,546 | 24.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 30 | 31 | $34,477 | $3,041 | 8.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 55 | $13,530 | $2,972 | 22.0% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 21 | 22 | $20,592 | $1,832 | 8.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 18 | $6,516 | $1,342 | 20.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 15 | $5,430 | $1,130 | 20.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 15 | 17 | $6,973 | $749.50 | 10.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 69 | $1,425 | $204.75 | 14.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 14 | 8,165 | $113,902 | $36,921 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 267 | $47,526 | $22,807 | 48.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 104 | 104 | $33,280 | $12,059 | 36.2% |
About Dr. Patrick Matthiessen, MD
Dr. Patrick Matthiessen, MD is a Neurology healthcare provider based in La Grange, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306833124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Matthiessen, MD has received a total of $61,691 in payments from pharmaceutical and medical device companies, with $21,751 received in 2024. These payments were reported across 443 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,956).
As a Medicare-enrolled provider, Matthiessen has provided services to 3,404 Medicare beneficiaries, totaling 28,786 services with total Medicare billing of $437,732. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location La Grange, KY
- Active Since 10/06/2005
- Last Updated 12/12/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306833124
Products in Payments
- UBRELVY (Drug) $30,589
- Leqembi (Drug) $17,251
- QULIPTA (Drug) $6,696
- VNS Therapy (Device) $1,624
- KISUNLA (Drug) $395.18
- Nayzilam (Drug) $280.86
- MAYZENT (Drug) $236.20
- APTIOM (Drug) $235.97
- TYSABRI (Biological) $234.86
- KESIMPTA (Drug) $213.98
- VNS - Sentiva (Device) $202.85
- FYCOMPA (Drug) $185.30
- AMYVID (Drug) $174.82
- Austedo XR (Drug) $143.94
- Mavenclad (Drug) $124.11
- ENROUTE Transcarotid Neuroprotection System (Device) $119.25
- RYTARY (Drug) $116.52
- XCOPRI (Drug) $113.67
- ZAVZPRET (Drug) $96.44
- Aimovig (Biological) $96.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.